Thursday, September 6, 2018

Investor Ideas #Potcasts #Cannabis News and #Stocks on the Move: TSX: $APH.TO, TSX: $WEED.TO, NYSE: $CGC, CSE: $HIKU.C, TSXV: $N.V


Investor Ideas #Potcasts #Cannabis News and #Stocks on the Move: TSX: $APH.TO, TSX: $WEED.TO, NYSE: $CGC, CSE: $HIKU.C, TSXV: $N.V


Delta, Kelowna, BC –September 6,  2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca  release today’s edition of its series, Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:


Today’s podcast overview/transcript:

Good morning and welcome to another Investorideas.com potcast – looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today we will be looking at announcements from Aphria Inc. trading on the TSX as APH and US OTC as APHQF, Canopy Growth Corporation trading on the TSX as WEED and the NYSE as CGC, Hiku Brands Company Ltd. trading on the CSE as HIKU and Namaste Technologies Inc. trading on the TSX-Venture as N.

Canopy Growth Corporation and Hiku Brands Company Ltd. announced the closing of the previously announced acquisition of Hiku by Canopy Growth.
Today's announcement follows Hiku's special meeting of shareholders held on August 30, 2018 where holders of the common shares of Hiku voted to approve the Transaction.

As a result of the Transaction, Hiku has become a wholly-owned subsidiary of Canopy Growth and the Hiku Shares are anticipated to be de-listed from the Canadian Securities Exchange as of today. Trading of the Hiku Shares was halted on the Canadian Securities Exchange as of noon on August 31, 2018. Pursuant to the Transaction, Canopy Growth acquired 100% of the issued and outstanding common shares of Hiku and Hiku shareholders are entitled to receive 0.046 of a Canopy Growth common share in exchange for each Hiku Share held immediately prior to the closing.

Aphria Inc. today announced that it has entered into a share purchase agreement with a group of buyers, each acting individually and not in concert, including a member of the Serruya family, and has completed the sale of 64,118,462 shares in Liberty Health Sciences, Inc., representing 100% of the Company's outstanding investment in Liberty. As part of the transaction, Aphria retains an irrevocable option to repurchase the Shares or any replacement securities from the buyers for a period of up to five years, subject to the satisfaction of certain conditions as further described below. As a result of the transaction, Aphria has divested its remaining U.S. cannabis assets from its balance sheet in accordance with the staff notice and requirements of the Toronto Stock Exchange ("TSX"). As a result of this divestiture, the Company has significantly improved its liquidity position while it continues to focus on the many opportunities within Canada and in other legal cannabis markets around the world.

"Given the current federal legal framework in the United States, we have made the strategic decision to divest our remaining U.S. holdings at this time in order to permit us to focus on other more immediate capital markets and strategic opportunities in Canada and in other legal markets around the world," said Vic Neufeld, Chief Executive Officer of Aphria. "Not only does this transaction result in a significant gain to the Company it also enables Aphria to advance its existing global strategic plan unencumbered by U.S. exposure at this time."

Namaste Technologies Inc. announced that the Company has signed an exclusive co-supply, marketing, and distribution agreement with Airo Brands Inc. to launch Airo Brands' pre-filled vaporizer cartridge brand in both the recreational and medical cannabis markets throughout Canada. As part of the arrangement, Namaste will produce and distribute Airo Brand's pre-filled vaporizer cartridges through the Company's wholly-owned subsidiary and Health Canada's Access to Cannabis for Medical Purposes Regulations ("ACMPR") Licensed Producer, Cannmart Inc.
This Agreement represents a strategic partnership between Namaste and Airo Brands to leverage Namaste's resources and Airo Brands established product, brand image and reputation. Through Infinite Labz, Namaste believes it has the capacity to become the "go to" service provider in this high growth, high margin market of pre-filled cartridges. Namaste's investment in Infinite Labz Inc., which is a purpose-built facility for producing cannabis oil under the ACMPR regulations is located directly across the street from Cannmart. Infinite Labz will provide oil production services that will provide supply for Airo Brands' and other products which Namaste will bring to the online medical and recreational markets. To be partnering with one of the leading US-based producer of pre-filled vaporizers further validates Namaste's strategy and is a monumental step forward for the Company. Namaste plans to work with Airo Brands to exclusively source the highest quality cannabis oil and to facilitate production, packaging and distribution through Cannmart.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher,  iHeartradio, Spreaker and Tunein.

If you would like to be a guest or sponsor this podcast contact Investorideas.com


Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: http://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the Stock Guru daily podcast on Support and Resistance Trading.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: http://www.investorideas.com/About/Private_Policy.asp


Follow us on Social Media





Contact Investorideas.com
800-665-0411




Do you trade or invest in Marijuana / Hemp Stocks?  Check out our stock directory of publicly traded  CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks
Join our Group on Linkedin  and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing


Wednesday, September 5, 2018

Investor Ideas #Potcasts #Cannabis News and #Stocks on the Move: TSX: $APH.TO, TSX: $TRST.TO, TSX: $CHH.TO, TSX: $WEED.TO, TSXV: $N.V


Investor Ideas #Potcasts #Cannabis News and #Stocks on the Move: TSX: $APH.TO, TSX: $TRST.TO, TSX: $CHH.TO, TSX: $WEED.TO, TSXV: $N.V




Delta, Kelowna, BC –September 5, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca  release today’s edition of its series, Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:


Today’s podcast overview/transcript:

Good morning and welcome to another Investorideas.com potcast – looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today we will be looking at announcements from Aphria Inc. trading on the TSX as APH and US OTC as APHQF, CannTrust Holdings Inc. trading on the TSX as TRST, Centric Health Corporation trading on the TSX as CHH, Canopy Growth Corporation trading on the TSX as WEED and the NYSE as CGC and Namaste Technologies Inc. trading on the TSX-Venture as N.

Aphria Inc. and Rapid Dose Therapeutics Inc., a Canadian bio-technology company focused on innovative drug delivery solutions, announced today that they have signed a non-binding Memorandum of Understanding ("MOU") related to RDT's QuickStrip™ products. Under the terms of the MOU, the companies intend to enter into a definitive agreement in the near future pursuant to which RDT will provide Aphria with exclusive global preferred rights to produce, distribute and sell QuickStrip™ products for cannabis markets around the world.
This proposed strategic partnership highlights Aphria's persistent focus on innovation with a view to incorporating the latest technologies to revolutionize the way patients and consumers integrate cannabis into their lives. RDT's innovative QuickStrip™ is an easy-to-use, safe and effective oral fast-dissolving drug delivery system, developed in conjunction with McMaster University through the renowned Adronov Research Group, that provides accurate dosing and potency. With this technology, Aphria intends to produce oral thin strips for both the medical and adult-use cannabis markets.

CannTrust Holdings Inc., one of Canada's leading and most trusted licensed producers of cannabis, announced today that it will collaborate with Hamilton Health Sciences and McMaster University ("McMaster") in Hamilton, Ontario on upcoming medical research studies. Hamilton Health Sciences and McMaster are known world-wide for innovation in education and research, and for its role in developing evidence-based medicine. This partnership strengthens CannTrust's existing commitment to innovation and its contribution to generating evidence regarding the therapeutic use and clinical effectiveness of cannabinoids.

CannTrust will be working with the Michael G. DeGroote Pain Clinic of Hamilton Health Sciences and McMaster University, and the Michael G. DeGroote Institute for Pain Research and Care of McMaster University on a range of upcoming randomized placebo controlled clinical trials (RCT), representing the first Canadian University partnership for the Company. Utilizing CannTrust's broad range of quality cannabis products, the first clinical trial, Cannabis Oil for Chronic Non-Cancer Pain Treatment (CONCEPT), is expected to begin this fall, with additional studies to follow.
The results of these studies will be crucial for researchers, health care practitioners and policy makers to use cannabinoids for designing more effective, safer treatment protocols and public health policies. Throughout the partnership, CannTrust will utilize its more than 40 years of pharmacy, healthcare experience and knowledge to help McMaster and Hamilton Health Sciences study the application of the Company's products as treatment for various patient needs.
An analysis of CannTrust's 48,000 existing customer profiles indicates that pain is one of the primary reasons for utilizing medical cannabis, highlighting the need for trials in this area. Through research at the Centre, CannTrust aims to help healthcare professionals and patients better understand the possible benefits of medical cannabis for those living with pain-related conditions, and beyond.

Centric Health Corporation today announced that it has entered into multi-year supply and service agreements with Canopy Growth Corporation for the provision of medical cannabis. Under the agreements, Canopy Growth will be the preferred education partner and supplier of choice of medical cannabis primarily through its Spectrum Cannabis brand to Centric Health and the seniors that it serves both in long-term care and retirement residences, as well as seniors living in the community.
Spectrum Cannabis and Centric Health will work collaboratively to educate Centric Health's clinical pharmacists, as well as other healthcare partners, residents and seniors and their families, on the benefits and potential applications of medical cannabis. Centric Health's clinical pharmacists are in an ideal position to provide guidance on the safe use of medical cannabis as they are specially trained in geriatric medicine. Many seniors face significant barriers when it comes to access and knowledge around the benefits of medical cannabis but with the support of trained pharmacists and educators, the seniors that Centric Health serves and those living within the community will have the ability to receive assessments and on-going support from a pharmacist to ensure the highest degree of safety and efficacy. Centric Health's unwavering commitment to quality care and resident outcomes through their existing pharmacy operations and focused strategy of expanding service offerings to seniors in the community makes for an ideal long-term strategic partnership. 

Namaste Technologies Inc. announced that the Company has achieved a 300% month-on-month growth rate in its Canadian marketplace, in comparison with August of 2017, and 50% growth globally. In the month of August of 2018, the Company generated $1.65M in revenue which represents a 50% increase in revenue in comparison with August of 2017 after consideration of the loss of revenue due to Namaste divesting its US assets that were incorporated into its 2017 sales. The Company has also achieved over 300% growth on its Canadian websites, which now includes over 17,000 customers. 

The Company has been focused on developing its Canadian market by enhancing its e-commerce platform and focusing on organic growth through content production, search-engine optimization ("SEO") and in implementation of its proprietary AI technology through the Company's wholly-owned subsidiary, Findify AB ("Findify" or "Findify.io"). With increased competition in the Canadian market, Namaste is pleased to have achieved such significant growth in a key market for the Company.
In anticipation of receiving Canada's first medical cannabis "sales-only" license, under the guidelines of Health Canada's ACMPR, expansion of its Canadian platform including hardware sales as well as registered users in both NamasteMD ("NamasteMD.com") and My Uppy Cannabis ("My Uppy") Journal represent significant advances for the Company as it looks forward to launching cannabis sales into its Canadian e-commerce marketplace.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher,  iHeartradio, Spreaker and Tunein.

If you would like to be a guest or sponsor this podcast contact Investorideas.com


Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: http://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the Stock Guru daily podcast on Support and Resistance Trading.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: http://www.investorideas.com/About/Private_Policy.asp


Follow us on Social Media





Contact Investorideas.com

800-665-0411




Do you trade or invest in Marijuana / Hemp Stocks?  Check out our stock directory of publicly traded  CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks
Join our Group on Linkedin  and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing



Tuesday, September 4, 2018

Investorideas.com - CannaTech Sydney: Australia's First Ever Global Medical Cannabis Summit

Investorideas.com - CannaTech Sydney: Australia's First Ever Global Medical Cannabis Summit

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investorideas.com - Cape & Plymouth Business Announces #Cannabiz: The Business Impact of Legalization

Investorideas.com - Cape & Plymouth Business Announces #Cannabiz: The Business Impact of Legalization

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investorideas.com - #Cannabisstocks: Alternate Health (CSE:AHG) (OTCQB:AHGIF) signs agreement with Liberty Health Sciences to launch Florida's first online shopping portal for #medicalcannabis

Investorideas.com - #Cannabisstocks: Alternate Health (CSE:AHG) (OTCQB:AHGIF) signs agreement with Liberty Health Sciences to launch Florida's first online shopping portal for #medicalcannabis

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investor Ideas #Potcasts #Cannabis News and #Stocks on the Move: TSX: $ACB.TO, NASDAQ: $CRON, TSX: $APH.TO, CSE: $MTEC.C, TSXV: $N.V


Investor Ideas #Potcasts #Cannabis News and #Stocks on the Move: TSX: $ACB.TO, NASDAQ: $CRON, TSX: $APH.TO, CSE: $MTEC.C, TSXV: $N.V



Delta, Kelowna, BC –September 4, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca  release today’s edition of its series, Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the September 4 podcast:


Transcript of Today’s Podcast
Good morning and welcome to another Investorideas.com potcast – looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today we will be looking at announcements from Aurora Cannabis Inc. trading on the TSX as ACB and the OTCQB as ACBFF, Cronos Group Inc. trading on the NASDAQ and TSX as CRON, Aphria Inc. trading on the TSX as APH  OTC as APHQF, Cannvas MedTech Inc. trading on the CSE as MTEC and Namaste Technologies Inc. trading on the TSX-Venture as N.

Aurora Cannabis Inc. today announced that it has closed its previously announced debt facility with the Bank of Montreal ("BMO"). The facility consists of a $150 million term loan and a $50 million revolving credit facility, both of which mature in 2021. Included in the facility is an option to upsize the facility to $250 million total following the implementation of Bill C-45 on October 17, 2018, subject to agreement by BMO and satisfaction of certain legal and business conditions.
The debt facility is primarily secured by Aurora's production facilities, including Aurora Sky, Aurora Mountain, and Aurora Vie. Strategically located at Edmonton International Airport, Aurora Sky is the world's most technologically advanced cannabis facility, projected to produce in excess of 100,000 kg per year of high-quality, low-cost per gram, cannabis upon completion.

Today, Cronos Group Inc., a geographically diversified and vertically integrated cannabis group, and Ginkgo Bioworks Inc., the organism company, announced a landmark partnership to produce cultured cannabinoids. Using its platform technology for organism design and development, Ginkgo will complement Cronos Group's technologies for producing a full spectrum of cannabinoids. As part of this unprecedented deal, Cronos Group has agreed to issue a specific number of common shares in tranches subject to Ginkgo's achievement of certain production milestones. 

As two of the leading companies in their respective industries, Cronos Group and Ginkgo believe that they are best-suited to unlock the potential of innovation in the cannabis industry. Cronos Group brings a deep understanding of the plant's biological structure and function, while Ginkgo brings 10 years of experience designing microorganisms for the production of cultured products across pharmaceuticals, agriculture, flavors, fragrances, and more.
Cannabinoids span a range of molecules with different properties, and ongoing research has demonstrated potential medicinal uses for indications such as chronic pain, nervous disorders, nausea, weight loss, and some mental illnesses. However, many pharmaceutically relevant cannabinoids are present only at very low quantities in the cannabis plant, making them economically impractical, difficult or impossible to extract at high purity and scale. The landmark partnership between Cronos Group and Ginkgo will leverage the expertise of both organizations to solve this challenge and make more accessible the benefits of cannabinoids in an economically sustainable way.

Aphria Inc. today announced that it has entered into a strategic partnership with Schroll Medical, a subsidiary of prominent European flower producer, Schroll Flowers. The Partnership will pursue the cultivation and worldwide distribution of organic, EU GMP-certified medical cannabis, and will be managed by the Company's wholly-owned subsidiary Aphria Deutschland GmbH ("Aphria Germany"). The deal accelerates Aphria's global expansion, in collaboration with an established and world-class partner, with first product expected to be available by early 2019.

In exchange for a 15% interest in the Partnership, Aphria is providing €100,000 to the Partnership, its leadership in cannabis greenhouse cultivation and experience in processing and worldwide distribution. This will include, but is not limited to, consulting on GMP certification, cannabis genetics and strains, and proprietary growing IP. Aphria will also handle the worldwide distribution of medical cannabis produced by the Partnership, which is anticipated to be made available to markets in Germany, Luxembourg, Switzerland and other developing medical cannabis markets. As part of the deal, Aphria maintains a path to increase its ownership interest to 50% and a path to realize full liquidity, each under certain conditions.

Cannvas MedTech Inc., a leading business technology company in the cannabis space, is pleased to announce its vendor of choice for integration to its Artificial Intelligence (A.I) component powering the Cannvas.me cannabis education platform.
IBM Watson has been chosen to power the A.I. analytics branch of the Cannvas platform.  It will  serve as a best-in-class integrated solution most relevant and attuned for the persona-driven architecture of the platform.  Leveraging IBMs A.I. service allows the Cannvas team to quickly analyze through the copious amounts of data attributes comprising the Cannvas.me platform in a relevant and real-time fashion for its user base.
Deriving industry and customer insights in a real-time fashion for the CRM program requires the use of technologies that are at the leading edge of their space.  Utilizing IBM Watsons capabilities allows the Cannvas technology stack to achieve this goal.   Cannvas.me takes the traditional Email Customer Journey and transforms it into a true Omni-Channel approach where user preferences and insights are utilized to serve a fully personalized message experience through the channel of their choice.  Cannvas.me will be able to truly embrace the concept of Omni-Channel marketing.

Namaste Technologies Inc. announced that the Company has signed a veteran patient services agreement and a medical cannabis supply agreement with Breton CannaPharms Ltd. Breton CannaPharms has a very strong presence in veteran communities across Canada and the entire management team has extensive experience in holistically servicing veterans and educating communities on the positive and misunderstood effects of medical cannabis to treat veterans suffering from both chronic pain and post-traumatic stress disorder ("PTSD").

Under the terms of the Patient Services Agreement, Breton Farms will work exclusively with NamasteMD to target patient acquisition within veteran groups across the country. Namaste is proud to partner with Breton Cannabis to focus on acquiring veteran patients and servicing their needs through its Access to Cannabis for Medical Purposes Regulations ("ACMRP") Licensed Producer partners.  NamasteMD provides convenient access to nurse practitioners for medical consultations through online video and is available on the Apple Store, Google Play devices and online at NamasteMD.com.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher,  iHeartradio, Spreaker and Tunein.

If you would like to be a guest or sponsor this podcast contact Investorideas.com


Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: http://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the Stock Guru daily podcast on Support and Resistance Trading.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: http://www.investorideas.com/About/Private_Policy.asp


Follow us on Social Media





Contact Investorideas.com
800-665-0411




Do you trade or invest in Marijuana / Hemp Stocks?  Check out our stock directory of publicly traded  CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks
Join our Group on Linkedin  and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing